Morgan Stanley Names Dr. Reddy's (RDY) 'Long Research Tactical Idea'
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Price: $11.85 +0.17%
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Traders should watch shares of Dr. Reddy's Labs (NYSE: RDY) as Morgan Stanley just named the stock a "Long Research Tactical Idea."
The stock last traded at $29.70, down 0.77 percent for the session.
The stock last traded at $29.70, down 0.77 percent for the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macquarie Downgrades Roblox Corp. (RBLX) to Neutral
- Amazon.com (AMZN) PT Raised to $400 at Benchmark
- Amazon.com (AMZN) PT Raised to $318 at UBS
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
